The Phase 1 trial ANQUR, now testing two new doses of the ALS therapy QRL-201, is enrolling patients at 12 sites in Canada ...

Philadelphia dad Eric Brunner was diagnosed with amyotrophic lateral sclerosis, the fatal disease known as ALS. He wants to ...

The Gilbert family's resilience in the face of ALS highlights the crucial role of informal caregivers in America.

To partner with the ALS community to drive the discovery of prevention strategies, treatments, and cures for ALS; provide ...

But utreloxastat had little effect on ALS in the phase 2 trial. PTC powered the study to show whether twice-daily oral dosing ...

Instead of feeling down, Maya and Maceo focus on what's still possible, pushing the boundaries of what the preconceived ...

The Converge platform validated as many as 83% of its treatment targets in disease models, a higher success rate than usual ...

PTC Therapeutics said on Tuesday its drug did not meet the main goal in a mid-stage trial evaluating it in patients with a type of fatal neurodegenerative disease called amyotrophic lateral sclerosis.

Navigating apprenticeship and adult learner funding can sometimes feel overwhelming. Yet, with the right tools and mindset, ...